J7178 HCPCS Level II code: Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
J7178 is the HCPCS code for “Injection, human fibrinogen concentrate, not otherwise specified, 1 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7178Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
Short description: Inj human fibrinogen con nos
HCPCS · United States
Medicare details
The indicators CMS publishes with J7178 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2013
Where J7178 sits
- 1J codesDrugs administered other than orally
- 2Active code J7178Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7178 mean?
J7178 is the HCPCS code for “Injection, human fibrinogen concentrate, not otherwise specified, 1 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7178?
CMS lists J7178’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7178
All J codesJ7172Injection, marstacimab-hncq, 0.5 mgJ7173Injection, concizumab-mtci, 0.5 mgJ7174Injection, fitusiran, 0.04 mgJ7175Injection, factor x, (human), 1 i.u.J7176Injection, human fibrinogen - chmt (fesilty), 1 mgJ7177Injection, human fibrinogen concentrate (fibryga), 1 mgJ7179Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rcoJ7180Injection, factor xiii (antihemophilic factor, human), 1 i.u.J7181Injection, factor xiii a-subunit, (recombinant), per iuJ7182Injection, factor viii, (antihemophilic factor, recombinant), (novoeight), per iuJ7183Injection, von willebrand factor complex (human), wilate, 1 i.u. vwf:rcoJ7185Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.